Pfizer Vaccine Only 12% Effective in Kids 5 to 11, Study Says


A study released Monday showed the effectiveness of Pfizer’s COVID-19 vaccine in 5- to 11-year-olds was only 12% after a seven-week period of observation. According to The New York Times, federal health officials knew about the findings since early February.

The effectiveness of the Pfizer-BioNTech COVID-19 vaccine against Omicron “declined rapidly for children, particularly those 5-11 years,” according to astudyreleased February 28.

The authors of the study still recommended the vaccine for that age group, stating it was protective against severe disease. They also proposed the recommended dose for 5- to 11-year-olds was too small, suggesting a higher dose might solve the problem.

According to The New York Times, the study’s lead author, Dr. Eli Rosenberg, briefed Dr. Rochelle Walensky and other officials at the Centers for Disease Control and Prevention (CDC) on the New York data in early February.

U.S. Food and Drug Administration (FDA) officials…

View original post 1,421 more words

Author: Lawrence Morra

Have worked in creative and news visual media as a photographer or cameraman and this POV has given me a better insight or view of the world. The Cameraman's POV. His Perspective on many things. All content on this site is copyrighted© by Lawrence Morra/Zero Lift-Off. All rights reserved. Email:

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: